Skinvisible (SKVI) Receivables - Other (2010 - 2023)

Skinvisible has disclosed Receivables - Other across 13 years of filings, most recently posting $21592.0 for Q4 2023.

• Receivables - Other for Q4 2023 came in at $21592.0, up 53.43% year-over-year; the trailing twelve-month figure through Dec 2023 was $21592.0 (up 53.43% YoY), and the FY2023 annual result was $21592.0, up 53.43% from the prior year.
• Receivables - Other came in at $21592.0 for Q4 2023 at Skinvisible, up from $14073.0 in the prior quarter.
• In the past five years, Receivables - Other ranged from a high of $68899.0 in Q4 2019 to a low of $399.0 in Q2 2019.
• The 4-year median for Receivables - Other is $12138.5 (2019), against an average of $20918.1.
• Peak annual rise in Receivables - Other reached 5917.38% in 2019, while the deepest fall reached 65.15% in 2019.
• Skinvisible's Receivables - Other stood at $68899.0 in 2019, then plunged by 93.66% to $4370.0 in 2020, then soared by 222.04% to $14073.0 in 2022, then surged by 53.43% to $21592.0 in 2023.
• The last three Receivables - Other figures came in at $21592.0 (Q4 2023), $14073.0 (Q4 2022), and $4370.0 (Q2 2020), per Business Quant data.